Belimumab Dose Spacing May Be an Option for Selected Patients With SLE in Sustained Remission
As reported on MedScape, gradually extending the interval between belimumab doses may allow carefully selected patients with systemic lupus erythematosus (SLE) in long-term remission to reduce treatment exposure (and in…